Ewing's sarcoma
Top Cited Papers
- 28 February 2010
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 11 (2), 184-192
- https://doi.org/10.1016/s1470-2045(09)70286-4
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort studyThe Lancet Oncology, 2010
- A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcomaNature Medicine, 2009
- Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group StudyJournal of Clinical Oncology, 2009
- Phase II study of intermediate‐dose cytarabine in patients with relapsed or refractory Ewing sarcoma: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2009
- Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcomaMolecular Cancer Therapeutics, 2008
- Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2008
- Updates on p53: modulation of p53 degradation as a therapeutic approachBritish Journal of Cancer, 2008
- Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing’s sarcomaEuropean Journal of Cancer, 2006
- Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcomaEuropean Journal of Cancer, 2006
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidThe New England Journal of Medicine, 1999